Výsledky vyhledávání

Akademický článek

Treatment efficiency in patients with acute myeloid leukemia from 2019 to 2023 according to the Moscow Cancer Registry

Publikováno v: Онкогематология, Vol 19, Iss 3, Pp 99-111 (2024)

Aim. To evaluate the acute myeloid leukemia (AML) treatment efficacy in adults in Moscow real clinical practice according to the Moscow Cancer Registry data.Materials and methods. We retrospectively collected data from the Moscow Cancer Registry on M

Externí odkaz: https://doaj.org/article/7f315582fe1a4a3cb87996f49a846926

Zobrazit plný text záznamu

Akademický článek

COVID-19 in patients with acute lymphoblastic leukemia

Autor: T. S. Chudnova, E. N. Misyurina, E. A. Baryakh, T. N. Tolstykh, L. T. Shimanovskaya, D. E. Gagloeva, E. I. Zhelnova, A. B. Makeshova, K. V. Yatskov, E. N. Zotina, D. D. Ivanova, M. A. Mingalimov, O. L. Kochneva, E. Yu. Grishina, V. N. Yakimets

Publikováno v: Онкогематология, Vol 19, Iss 3, Pp 206-214 (2024)

Background. Patients with acute lymphoblastic leukemia (ALL) have been the most vulnerable group of patients at risk of severe and extremely severe COVID-19 throughout the coronavirus pandemic. Secondary immunodeficiency due to acute leukemia, as wel

Externí odkaz: https://doaj.org/article/84e5c35a50cc4b5eade5ae9d63731241

Zobrazit plný text záznamu

Akademický článek

Persistence of a new coronavirus infection in a patient with primary central nervous system large B-cell lymphoma with assessment of the humoral immune response against SARS-CoV-2

Autor: Yu. Yu. Polyakov, E. A. Baryakh, E. N. Misyurina, E. I. Zhelnova, M. A. Mingalimov, S. A. Kardovskaya, M. Ya. Smolyarchuk, T. N. Tolstykh, T. S. Chudnova, D. D. Ivanova, O. L. Kochneva, D. V. Lebedev, A. U. Abueva, A. M. Chistov, E. N. Zotina, I. V. Samsonova, M. A. Lysenko

Publikováno v: Онкогематология, Vol 19, Iss 2, Pp 101-108 (2024)

Treatment of immunocompromised patients with novel coronavirus infection (COVID-19) presents significant challenges. Currently, there are no unified approaches to the treatment of persistent COVID-19 in hematological malignancies. There is a need to

Externí odkaz: https://doaj.org/article/6ad4e363aae34c35b0a8dbd147ff46eb

Zobrazit plný text záznamu

Akademický článek

Sinonasal diffuse large B-cell lymphoma: own clinical observation and literature review

Autor: M. A. Mingalimov, E. A. Baryakh, O. L. Kochneva, E. N. Misyurina, Yu. Yu. Polyakov, E. I. Zhelnova, K. V. Yatskov, A. B. Makeshova, T. N. Tolstykh, T. S. Chudnova, D. D. Ivanova, D. V. Lebedev, E. N. Zotina, D. E. Gagloeva, M. M. Beregov, E. A. Mamatturdiev, I. V. Samsonova, M. A. Lysenko

Publikováno v: Онкогематология, Vol 19, Iss 2, Pp 75-82 (2024)

Diffuse large B-cell lymphoma is the most common immunomorphological variant of lymphoma in adults. Extranodal lesions are observed in a third of patients at the disease onset. The organs most often involved are the gastrointestinal tract, testicles,

Externí odkaz: https://doaj.org/article/778f7ec549ee43658eeee7c8bd204bc8

Zobrazit plný text záznamu

Akademický článek

Chronic lymphocytic leukemia in combination with COVID-19: clinical features and unfavorable prognosis factors

Autor: O. L. Kochneva, E. A. Baryakh, E. N. Misyurina, E. I. Zhelnova, K. V. Yatskov, T. S. Chudnova, Yu. Yu. Polyakov, A. B. Makeshova, M. A. Mingalimov, D. D. Ivanova, L. T. Shimanovskaya, E. N. Zotina, T. N. Tolstykh, E. Yu. Grishina, D. E. Gagloeva, V. N. Yakimets, A. I. Koneva, E. A. Karimova

Publikováno v: Онкогематология, Vol 18, Iss 4, Pp 64-73 (2024)

Background. At the end of 2019, a new coronavirus infection caused by the SARS-CoV-2 virus was registered. In March 2020, the first cases of COVID-19 were detected in Moscow. Patients with chronic lymphocytic leukemia, characterized by profound immun

Externí odkaz: https://doaj.org/article/28110400142b4f29a4bdd886c5d5d04d

Zobrazit plný text záznamu

Akademický článek

COVID-19 in patients with acute leukemia: 3 years' experience of pandemic

Publikováno v: Онкогематология, Vol 18, Iss 4, Pp 45-52 (2024)

Patients with acute leukemia are one of the most vulnerable risk groups for infection with SARS-CoV-2 and severe course of coronavirus infection. During the first 2 years of the pandemic, the mortality rate of patients with acute leukemia was 11-48 %

Externí odkaz: https://doaj.org/article/562373b3d4a34ce08d461076cd4f6999

Zobrazit plný text záznamu

Akademický článek

Treatment features of adult patients with acute myeloid leukemia during the COVID-19 pandemic

Autor: D. E. Gagloeva, E. N. Misyurina, T. N. Tolstykh, E. A. Baryakh, K. V. Yatskov, E. A. Karimova, A. B. Makeshova, M. A. Mingalimov, T. S. Chudnova, D. D. Ivanova, A. I. Koneva, O. L. Kochneva, E. N. Zotina, E. Yu. Grishina, L. T. Shimanovskaya, V. N. Yakimets, E. I. Zhelnova

Publikováno v: Онкогематология, Vol 18, Iss 4, Pp 40-44 (2024)

Background. Acute myeloid leukemia (AML) is a highly aggressive oncological disease of the blood and bone marrow, requiring extremely toxic chemotherapy and massive supportive treatment to achieve stable remission. Currently, there is no work to prov

Externí odkaz: https://doaj.org/article/5e92b8d878a544aeace85f666ff5d035

Zobrazit plný text záznamu

Akademický článek

Basic therapeutic approaches to the management of hematology/oncology patients with new coronavirus infection (COVID-19)

Publikováno v: Онкогематология, Vol 18, Iss 4, Pp 10-39 (2024)

In December 2019, cases of severe respiratory infection were reported in Wuhan, China. The disease was caused by a new, previously undescribed coronavirus, structurally similar to the then known SARS-CoV virus. The World Health Organization has named

Externí odkaz: https://doaj.org/article/6c9982b78af94d8e92e3fb3b76bf0c82

Zobrazit plný text záznamu

Akademický článek

Prognostic model and risk factors for hospital mortality in patients with diffuse large B-cell lymphoma associated with coronavirus infection: a single-center cohort study

Autor: Yu. Yu. Polyakov, E. A. Baryakh, E. N. Misyurina, E. I. Zhelnova, K. V. Yatskov, A. B. Makeshova, M. A. Mingalimov, T. N. Tolstykh, T. S. Chudnova, D. D. Ivanova, A. I. Koneva, O. L. Kochneva, E. N. Zotina, D. E. Gagloeva, E. Yu. Grishina, L. T. Shimanovskaya, V. N. Yakimets

Publikováno v: Онкогематология, Vol 18, Iss 4, Pp 74-85 (2024)

Background. Coronavirus disease (COVID-19), caused by SARS-CoV-2, presents new challenges to hematologists, highlighting the vulnerability of patients with hematological malignancies, in particular with diffuse large B-cell lymphoma (DLBCL). Identifi

Externí odkaz: https://doaj.org/article/6d577e6096394b05aacb0118ea2f445b

Zobrazit plný text záznamu

Akademický článek

Treatment experience of coronavirus infection associated with SARS-CoV-2 in patients with acute myeloid leukemia in the older age group

Autor: L. T. Shimanovskaya, E. N. Misyurina, E. A. Baryakh, E. I. Zhelnova, K. V. Yatskov, T. S. Chudnova, A. B. Makeshova, M. A. Mingalimov, D. D. Ivanova, O. L. Kochneva, E. N. Zotina, T. N. Tolstykh, E. Yu. Grishina, D. E. Gagloeva, Yu. Yu. Polyakov, V. N. Yakimets, A. I. Koneva

Publikováno v: Онкогематология, Vol 18, Iss 4, Pp 53-63 (2024)

Aim. To study the course of COVID-19 (COronaVIrus Disease 2019) in elderly patients with acute myeloid leukemia (AML), to analyze risk factors for unfavorable outcome.Materials and methods. The paper presents our own experience in the treatment of el

Externí odkaz: https://doaj.org/article/fa10cb71761a4699b81be67c9d740c42

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání